Free account + included starter software — credential review typically takes 1–2 business days. See how it works
TRETINOIN CREAM 0.1% 45 G - 1 mg/g CREAM
Request Item

TRETINOIN CREAM 0.1% 45 G

Generic: tretinoin

TRETINOIN CREAM 0.1% 45 G

NDC:51672-1395-09
Manufacturer:Sun Pharmaceutical Industries, Inc.
Strength:1 mg/g
Dosage Form:CREAM
Route:TOPICAL

Sign up to see pricing

Licensed pharmacies, clinics, doctor's offices, and veterinary practices get instant account approval

Sign Up — Instant Approval

Drug Information

Identification

Generic Name

tretinoin

Brand Name

Tretinoin

Labeler / Distributor

Sun Pharmaceutical Industries, Inc.

Product Type

HUMAN PRESCRIPTION DRUG

Administration

Dosage Form

CREAM

Route of Administration

TOPICAL

FDA Application Number

ANDA211645

Active Ingredients

IngredientStrength
TRETINOIN1 mg/g

Pharmacological Class

RetinoidRetinoids [CS]

Data sourced from openFDA / DailyMed. For full prescribing information, consult the drug label.

Clinical Drug Information

Indications & Usage

Indications and Usage Tretinoin cream is indicated for topical application in the treatment of acne vulgaris. The safety and efficacy of the long-term use of this product in the treatment of other disorders have not been established.

Warnings

Warnings Keep out of reach of children. Keep tube tightly closed. Do not expose to heat or store at temperatures above 120°F (49°C).

Dosage & Administration

Dosage and Administration Tretinoin Cream should be applied once a day, before retiring, to the skin where acne lesions appear, using enough to cover the entire affected area lightly. Application may cause a transitory feeling of warmth or slight stinging. In cases where it has been necessary to temporarily discontinue therapy or to reduce the frequency of application, therapy may be resumed or frequency of application increased when the patients become able to tolerate the treatment. Alteration of vehicle, drug concentration, or dose frequency should be closely monitored by careful observation of the clinical therapeutic response and skin tolerance. During the early weeks of therapy, an apparent exacerbation of inflammatory lesions may occur. This is due to the action of the medication on deep, previously unseen lesions and should not be considered a reason to discontinue therapy. Therapeutic results should be noticed after two to three weeks but more than six weeks of therapy may be required before definite beneficial effects are seen. Once the acne lesions have responded satisfactorily, it may be possible to maintain the improvement with less frequent applications, or other dosage forms. Patients treated with tretinoin acne treatment may use cosmetics, but the area to be treated should be cleansed thoroughly before the medication is applied. (See Precautions )

Adverse Reactions

Adverse Reactions The skin of certain sensitive individuals may become excessively red, edematous, blistered, or crusted. If these effects occur, the medication should either be discontinued until the integrity of the skin is restored, or the medication should be adjusted to a level the patient can tolerate. True contact allergy to topical tretinoin is rarely encountered. Temporary hyper- or hypopigmentation has been reported with repeated application of tretinoin. Some individuals have been reported to have heightened susceptibility to sunlight while under treatment with tretinoin. To date, all adverse effects of tretinoin have been reversible upon discontinuance of therapy (see Dosage and Administration Section ).

Clinical data sourced from openFDA drug labeling. For complete prescribing information, consult the full drug label.